Publications
5891 Results
- Journal / Conference
- Quality of Life Research 18:147-155
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9916
Chemotherapeutic impact on pain and global health-related quality of life in homone-refractory prostate cancer: dynamically modified outcomes analysis of a randomized controlled trial [PMC2859212; PMID19130298]
- Journal / Conference
- American Journal of Clinical Oncology 32:453-459
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0312
A phase II study of gemcitabine and capecitabine in patients with advanced renal cell cancer (RCC): Southwest Oncology Group Study S0312 [PMID 19487915;PMC3394591]
- Journal / Conference
- Journal of Urology 181(2):512-516
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8949
Predictors of survival in advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949 [PMID19100570; PMC3394523]
- Journal / Conference
- Journal of Clinical Oncology 27(34):5788-5793
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0317
A phase II study of erlotinib (OSI-774) in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317 [PMC2793000; PMID19884559]
- Journal / Conference
- Journal of Clinical Oncology 27(9):1419-1425
- Year
- 2009
- Research Committee(s)
- Gynecologic
- Study Number(s)
- G0182
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer, a phase III trial of the Gynecologic Cancer InterGroup (GCIG) [PMC2668552;PMID19224846]
- Journal / Conference
- Journal of Clinical Oncology 27(30):4973-4979
- Year
- 2009
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8897
Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for breast cancer: results from an ancillary study to Southwest Oncology Group Trial S8897 (INT-0102). [PMC2799053;PMID19752340]
- Journal / Conference
- Leukemia and Lymphoma 50(5):728-735
- Year
- 2009
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0108
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-hodgkins lymphoma: Southwest Oncology Group study S0108 [PMID19373598; PMC3532923]
- Journal / Conference
- Journal of Clinical Oncology 27(1):114-119
- Year
- 2009
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8516 (INT-0067)
Natural history of central nervous system (CNS) relapse in patients with aggressive non-hodgkin's lymphoma: a 20 year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group [PMID19047289]
- Journal / Conference
- Journal of Clinical Oncology 27(15):2450-2456
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346, S9916
Prostate-specific antigen progression (PSA-P) predicts overall survival (OS) in patients with metastatic prostate cancer: data from Southwest Oncology Group (SWOG) trials 9346 (INT 0162) and 9916 [PMC2684851; PMID19380444]
- Journal / Conference
- Journal of Urology 181(6):2476-2480
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0219